• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

CLSN:US

3.4000 USD 0.0600 1.73%

As of 11:16:30 ET on 07/31/2014.

Snapshot for Celsion Corp (CLSN)

Open: 3.4600 Day's Range: 3.3901 - 3.4950 Volume: 48,306
Previous Close: 3.4600 52wk Range: 2.8200 - 6.6150 1-Yr Rtn: -37.56%

Stock Chart for CLSN

No chart data available.
  • CLSN:US 3.4000
  • 1D
  • 1M
  • 1Y
3.4600
Interactive CLSN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLSN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8207
Est. EPS (USD) (12/2014) -1.3700
Est. PEG Ratio -
Market Cap (M USD) 59.40
Shares Outstanding (M) 17.22
30 Day Average Volume 166,369
Price/Book (mrq) 1.4433
Price/Sale (ttm) 182.9675
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLSN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CLSN

Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.

Michael H TardugnoPresident/CEOJeffrey W Church "Jeff"CFO/Divisional VP/Secy
Khursheed AnwerExec VP/Chief Scientific OfcrNicholas BorysVP/Chief Medical Officer
More Company Profile & Key Executives for CLSN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil